DOI QR코드

DOI QR Code

Effect of Ginseng Radix Rubra Herbal-acupuncture Solution(GRR-HAS) on Gene Expression in SNU484 carcinomar cells

홍삼약침액(紅蔘藥鍼液)의 위암세포주(胃癌細胞柱) 유전자(遺傳子) 발현(發顯)에 미치는 영향(影響)

  • Won, Eun-Ju (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University) ;
  • Lee, Kyung-Min (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University) ;
  • Lee, Bong-Hyo (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University) ;
  • Lim, Seong-Chul (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University) ;
  • Jung, Tae-Young (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University) ;
  • Seo, Jung-Chul (Department of Acupuncture & Moxibustion, College of Oriental Medicine, Daegu Haany University)
  • 원은주 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 이경민 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 이봉효 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 임성철 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 정태영 (대구한의대학교 한의과대학 침구경혈학교실) ;
  • 서정철 (대구한의대학교 한의과대학 침구경혈학교실)
  • Published : 2006.06.30

Abstract

Objective : It has long been known about the anticancer effect of GRR-HAS, however, it has not been systemically determined the differentially regulated genes by GRR-HAS in cancer cells. The purpose of this study is to screen the GRR-HAS mediated differentially expressed genes in cancer cells such as SNU484 gastric cancer cell lines. Oligonucleotide microarray approache was employed to screen the differential expression genes. Methods : GRR-HAS was prepared by boiling and stored at $-70^{\circ}C$ until use. Cells were treated with various concentrations of GRR-HAS(0.1, 0.5, 1.5, 10, 20mg/ml) for 24 h. Cell toxicity was tested by MTT assay. To screen the differentially expressed genes in cancer cells, cells were treated with 1.5mg/ml of GRR-HAS. For oligonucleotide microarray assay, total RNA was used for gene expression analysis using oligonucleotide Genechip (Human genome Ul33 Plus 2.0., Affimatrix Co.). Results : It has no cytotoxic effects on both HepG2 and SNU484 cells in all concentrations(0.1, 0.5, 1.5, 10, 20mg/ml). In oligonucleotide microarray assay, in SNU484 cells, the number of more than twofold up-regulated genes was 346. The number of more than twofold down-regulated genes was 9. Discussion : This study showed the comprehensive gene expression analysis using oligonucleotide microarray for the screening of GRR-HAS mediated differentially regulated genes. These results will provide a better application of GRR-HAS in cancer field and drug target development.

Keywords

References

  1. 통계청. 2003년 사망원인통계연보. 대전 : 통계청. 2004 : 22-4.
  2. 서울대학교 의과대학. 종양학. 서울:서울대학교 출판부. 1992: 1, 3, 27, 36, 91, 99, 137-192.
  3. 賈堃. 癌瘤防治硏究. 서울 : 成輔社. 1984: 25-7.
  4. 方藥中. 實用中醫內科學. 上海 : 上海科學技術出版社. 1986 : 621-36.
  5. 全國韓醫科大學 本草學敎室 編. 本草學. 서울 : 永林社. 1991: 621-3.
  6. 장성강, 김주헌, 정윤선, 안동춘, 강명재, 이동근, 김상호. 한국 홍삼의 면역활성 및 항암효과에 관한 실험적 연구. 고려인삼학회지. 1994 ; 18(3) : 151-60
  7. 이혜연, 이한수. 홍삼 추출물의 임파구 증식 및 활성 촉진효과. 高麗人蔘學會誌. 1998 ; 22(1) : 60-5.
  8. 곽이성, 김영숙, 신한재, 송용범, 박종대. 홍삼산성다당체(RGAP)와 항암제의 병용투여에 의한 항암시너지 효과. Journal of Ginseng Research, v.27, no.2, pp.47-51 https://doi.org/10.5142/JGR.2003.27.2.047
  9. 한상원, 서정철, 이윤호, 최제용. 鹿茸藥鍼液의 DNA chip을 利用한 遺傳子 發顯 分析. 大韓鍼灸學會誌. 2003 ; 20(3) : 34-44.
  10. 楊維傑 編. 黃帝內經素門靈樞錫解. 서울 : 成輔社. 1980:41, 45, 97, 168, 243, 295-6, 407, 447, 469, 473, 577.
  11. 許俊. 東醫寶鑑. 서울 : 南山堂. 1988: 486-96, 720.
  12. 田炳旭. 癌腫의 病因病理에 대한 文獻的 考察. 大韓韓方腫瘍學曾誌. 1995; 1(1) : 83-101.
  13. 全國韓醫科大學 鍼灸.經穴學敎室 編. 鍼灸學 <下>. 서울 : 集文堂. 1994: 1457-67
  14. 임사비나, 한상원, 변부형. 人蔘藥鍼과 Lidocaine을 添加한 人蔘藥鍼이 腫瘍 및 免疫機能에 미치는 影響. 東西醫學. 1995 ; 20(3) : 21-40.
  15. 김소형, 김갑성. 全蝎 藥鍼液의 抗突然變異 및 抗癌 効果. 大韓鍼灸學會誌. 2000; 17(3): 151-67.
  16. 李俊茂, 河智容. 蠐螬藥鍼의 抗癌作用에 관한 硏究. 大韓東醫病理學會誌. 2000; 14(2) : 132-43.
  17. 지형준. 대한약전 및 대한약전 외 한약규격주해 서울:한국메디칼인텍스사. 1998 : 681-2.
  18. El-Aneed A. Current strategies in cancer gene therapy. European Journal of Pharmacology. 2004 ; 498(1-3) : 1-8. https://doi.org/10.1016/j.ejphar.2004.06.054
  19. Guimaraes MJ. Lee F, Zlotnik A, McClanahan T. Differential display by PCR : novel findings and applications. Nucleic Acids Res. 1995; 23(10) : 1832-3. https://doi.org/10.1093/nar/23.10.1832
  20. Kurian K, Watson CJ, Wyllie AH. DNA chip technology. J Pathos. 1999 ; 187(3) : 267-71. https://doi.org/10.1002/(SICI)1096-9896(199902)187:3<267::AID-PATH275>3.0.CO;2-#
  21. DeRisi JL, Penland L, Brovn PO. Use of a cDNA micro array to analyse gene expression pasterns in human cancer. Nature Genet. 1996; 14(4) : 457-60. https://doi.org/10.1038/ng1296-457
  22. Schuler GD, Bonguski MS, Stewart EA, Stein LP, Gyapay G, Rice K, et al. A gene map of the human genome. Science. 1996; 274(5287) : 540-6. https://doi.org/10.1126/science.274.5287.540
  23. Hedric SM, Cohen Dr, Nielsen EA, Davis MM. Isolation of cDNA clones encoding T-cell specific membrane associated proteins. Nature. 1984 ; 308(5955) : 149-53. https://doi.org/10.1038/308149a0
  24. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of polymerase chain reaction. Science 1992 ; 257(5072) : 967-71. https://doi.org/10.1126/science.1354393
  25. Mason IJ, Taylor A, Williams JG, Sage H, Hugan BLM. Evidence from molecular cloning that SPARC, a major product of mouse embryopariental endoderm is related to an endothelial cell culture shockgly coprotein of Mr. 43000. EMBO J. 1986;5(7): 1465-72.
  26. Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 1992 ; 52(24) : 6966-8.
  27. http://www.affymetrix.com
  28. Groneveld D, Eckhardt ER, Coenen AJ, Martens GJ, Balm PH, Wendelaar Bonga SE. Expression of tilapia prepro-melanin-concentrating hormone mRNA in hypothalamic and neurohypophysial cells. J Mol Endocrinol. 1995; 14(2) : 199-207 https://doi.org/10.1677/jme.0.0140199
  29. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care. 2004 ; 7(4) : 427-34. https://doi.org/10.1097/01.mco.0000134363.53782.cb